Literature DB >> 22299552

Thalassaemia: a study on the perception of patients and family members.

I Abdul Wahab1, M Naznin, M Z Nora, A R Suzanah, M Zulaiho, A R Aidl Faszrul, W S Kamaruzaman.   

Abstract

Marked improvement in the management of thalassaemia has not been matched by progress in psychosocial rehabilitation as thalassaemia continues to pose challenges to patients and their family members. Few studies have been carried out in Malaysia to look at such issues. This study is therefore to explore the concerns, beliefs and feelings about thalassaemia. It was conducted in the year 2009 over 7 months on "focus groups", in patients aged 8-22 years and parents attending Paediatric Clinic of Tengku Ampuan Afzan Hospital, Kuantan, Pahang. Results showed that concerns and adverse impact were related to lower grades in education, poor self-image, less chance of employment, marriage, financial burden and social integration. Compliance to subcutaneous iron chelator was poor. There were various concerns related to blood transfusion therapy. It is evident that thalassaemia greatly affects the psychosocial dimensions and a more structured long term psychosocial support is needed to improve quality of life of patients.

Entities:  

Mesh:

Year:  2011        PMID: 22299552

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  13 in total

1.  Quality of Life in Children with Thalassemia and their Caregivers in India.

Authors:  Sapna Sharma; Bageshree Seth; Prashant Jawade; Madhavi Ingale; Maninder Singh Setia
Journal:  Indian J Pediatr       Date:  2016-12-07       Impact factor: 1.967

2.  Childbearing through the Lens of Women with Minor Thalassemia: A Qualitative Study.

Authors:  Khadijeh Sarayloo; Zahra Behboodi Moghadam; Khadijeh Mirzaii Najmabadi; Sharon Elizabeth Millen; Mohsen Saffari
Journal:  Galen Med J       Date:  2019-08-17

3.  Living in a misty marsh: A qualitative study on the experiences of self-care suffering of patients with thalassemia.

Authors:  Batool Pouraboli; Heidar Ali Abedi; Abbas Abbaszadeh; Majid Kazemi
Journal:  Iran J Nurs Midwifery Res       Date:  2014-02

4.  Exploring Iranian β-Thalassemia major patients' perception of barriers and facilitators of adherence to treatment: A qualitative study.

Authors:  Amir Emami Zeydi; Hossein Karimi Moonaghi; Abbas Heydari
Journal:  Electron Physician       Date:  2017-12-25

5.  Self-care in Patient with Major Thalassemia: A Grounded Theory.

Authors:  Batool Pouraboli; Heidar Ali Abedi; Abbass Abbaszadeh; Majid Kazemi
Journal:  J Caring Sci       Date:  2017-06-01

6.  Health-related quality of life among children with transfusion-dependent thalassemia: A cross-sectional study in Malaysia.

Authors:  Asrul Akmal Shafie; Irwinder Kaur Chhabra; Jacqueline Hui Yi Wong; Noor Syahireen Mohammed; Hishamshah Mohd Ibrahim; Hamidah Alias
Journal:  Health Qual Life Outcomes       Date:  2020-05-14       Impact factor: 3.186

7.  Experience of Uncertainty in Patients with Thalassemia Major: A Qualitative Study.

Authors:  Mehrnaz Ahmadi; Mahin Gheibizadeh; Maryam Rassouli; Abbas Ebadi; Marziyeh Asadizaker; Mojtaba Jahanifar
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-10-01

8.  EQ-5D-3L health state utility values in transfusion-dependent thalassemia patients in Malaysia: a cross-sectional assessment.

Authors:  Asrul Akmal Shafie; Irwinder Kaur Chhabra; Jacqueline Hui Yi Wong; Noor Syahireen Mohammed
Journal:  Health Qual Life Outcomes       Date:  2021-01-07       Impact factor: 3.186

9.  Concerns of Thalassemia Patients, Carriers, and their Caregivers in Malaysia: Text Mining Information Shared on Social Media.

Authors:  Yuen Chi Phang; Azleena Mohd Kassim; Ernest Mangantig
Journal:  Healthc Inform Res       Date:  2021-07-31

10.  Quality of life and challenges experienced by the surviving adults with transfusion dependent thalassaemia in Malaysia: a cross sectional study.

Authors:  Wai Cheng Foong; Kooi Yau Chean; Fairuz Fadzilah Rahim; Ai Sim Goh; Seoh Leng Yeoh; Angeline Aing Chiee Yeoh
Journal:  Health Qual Life Outcomes       Date:  2022-01-08       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.